The final, formatted version of the article will be published soon.
REVIEW article
Front. Epigenet. Epigenom.
Sec. Epigenetics and Metabolism
Volume 2 - 2024 |
doi: 10.3389/freae.2024.1424163
This article is part of the Research Topic Understanding the molecular crosstalk between metabolism and epigenetics View all articles
Interplay between epigenetics and metabolism controls cancer stem cell plasticity
Provisionally accepted- 1 The University of Hong Kong, Pokfulam, Hong Kong, SAR China
- 2 Kyung Hee University, Seoul, Republic of Korea
Tumors consist of cancer cells with different genetic, epigenetic, and phenotypic properties. Cancer stem cells are an important subpopulation of heterogeneous cancer cells and are capable of initiating and propagating tumors. The term cancer stem cells has become broader in efforts to understand their phenotypic plasticity to switch fates between self-renewal and differentiation. Cancer stem cell plasticity is significantly associated with the initiation of metastasis, resistance to therapy, and tumor recurrence. With our broadened knowledge of epigenetic regulation and metabolic reprogramming as key elements enabling such capabilities, an expansive body of literature has demonstrated the functional importance of each element in contributing to cancer stem cell characteristics. Recently, the direct interplay between epigenetic regulation and metabolic reprogramming has begun to be appreciated in the context of cancer stem cells with growing interest. In this review, we discuss the mechanisms by which cancer stem cells orchestrate the reciprocal regulation of cellular metabolism and epigenetic alterations. In the discussion, compelling, unanswered questions on this topic have been elaborated for the interest of the research community and how recent technological developments help tackle such research ideas. A comprehensive understanding of cancer stem cell attributes that are largely governed by epigenetic and metabolic reprogramming would enable the advancement of precise therapeutic options and the prediction of better responses to drugs, holding great promise in cancer treatment and cure.
Keywords: epigenetics, Cancer Stem Cell (CSC), Cancer Metabolism, Oncogenic reprogramming, Reciprocal Regulation
Received: 27 Apr 2024; Accepted: 30 Aug 2024.
Copyright: © 2024 Choi and Baek. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Inwha Baek, Kyung Hee University, Seoul, Republic of Korea
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.